8-K - Traws Pharma, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Traws Pharma, Inc. filed an 8-K on February 19, 2026, under Item 8.01 disclosing information in Exhibit 99.1 Press Release and Item 9.01 listing exhibits. The filing contains forward-looking statements involving substantial risks and uncertainties.

Key Takeaways

1Filing date: 2026-02-19

2Form type: 8-K

3Item 8.01 disclosure with forward-looking statements

4Exhibit 99.1: Press Release dated February 19, 2026

5Exhibit 104: Cover Page Interactive Data File

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

. Forward-Looking Statements This Current Report, including Exhibit 99.1, contains certain forward-looking statements that involve substantial risks and uncerta

Other Event

9.01

. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated February 19, 2026. 104 Cover Page Interactive Data File (em

Exhibits Only

Source Document

Exhibits (2)

8-K

FORM 8-K

99.1

EXHIBIT 99.1